Topiramate Tablet, Film Coated
Product Images NDC 51655-848

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 51655-848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)

Chemical structure diagram of topiramate, the active ingredient, showing its detailed molecular arrangement with various oxygen, carbon, and sulfur functional groups visible.*

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)

A line graph showing cumulative rates for time to first seizure over a 500-day period for topiramate at 50 mg/day and 400 mg/day doses. The graph compares two groups with sample sizes of 234 and 236 respectively, illustrating a higher cumulative seizure rate over time at the 50 mg/day dose compared to the 400 mg/day dose, with a p-value of 0.0002 indicating statistical significance.*

FDA Label Image

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies labeled Study 11 and Study 12. The vertical axis shows the change in average monthly migraine rate, and the chart includes statistical significance indicators for some topiramate doses.*

FDA Label Image

Label (51655 848 52 Rev A 02 23)

Topiramate Tablets USP 100 mg film-coated tablets packaging label displaying 30 tablets per bottle. The label includes storage instructions to keep at 20° to 25°C, warnings to keep out of reach of children, and to protect from moisture. Manufactured and repackaged by Northwind Pharmaceuticals, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.